Position history for BAKER BROS. ADVISORS LP's holdings in CELLDEX THERAPEUTICS INC NEW
BAKER BROS. ADVISORS LP holds 665,370 shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $21.1M as of 2026-Q1. CLDX represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$21.1M
Current Shares
665,370
Total Value Change
+$11.9M
Total Shares Change
+417,726
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 665,370 |
0.0% |
| $21.1M |
| 0.1% |
| $28.94 |
0 |
| 2025-Q4 | Unchanged | 665,370 | 0.0% | $18.1M | 0.1% | $26.43 | 0 |
| 2025-Q3 | Unchanged | 665,370 | 0.0% | $17.2M | 0.1% | $26.19 | 0 |
| 2025-Q2 | Increased | 665,370 | +168.7% | $13.5M | 0.1% | $20.29 | 54 |
| 2025-Q1 | Unchanged | 247,644 | 0.0% | $4.5M | 0.0% | $19.93 | 0 |
| 2024-Q4 | Unchanged | 247,644 | 0.0% | $6.3M | 0.1% | $25.12 | 0 |
| 2024-Q3 | Unchanged | 247,644 | 0.0% | $8.4M | 0.1% | $33.20 | 0 |
| 2024-Q2 | Unchanged | 247,644 | 0.0% | $9.2M | 0.1% | $37.01 | 0 |